ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 170 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,005,192 | -17.8% | 205,552 | +13.9% | 0.00% | -50.0% |
| Q1 2024 | $6,092,040 | +644.4% | 180,398 | +595.1% | 0.00% | – |
| Q4 2023 | $818,330 | +37.8% | 25,954 | +11.6% | 0.00% | – |
| Q3 2023 | $593,961 | +46.7% | 23,247 | +37.6% | 0.00% | – |
| Q2 2023 | $404,974 | 0.0% | 16,895 | 0.0% | 0.00% | – |
| Q1 2023 | $404,974 | -99.9% | 16,895 | -4.5% | 0.00% | – |
| Q1 2022 | $476,976,000 | -27.2% | 17,692 | 0.0% | 0.00% | – |
| Q4 2021 | $654,781,000 | -27.7% | 17,692 | -6.6% | 0.00% | – |
| Q3 2021 | $905,192,000 | +43.2% | 18,945 | +1.4% | 0.00% | – |
| Q2 2021 | $631,996,000 | -5.7% | 18,676 | +15.1% | 0.00% | – |
| Q1 2021 | $670,093,000 | +5.8% | 16,225 | +11.1% | 0.00% | – |
| Q4 2020 | $633,348,000 | +3.2% | 14,600 | +2.1% | 0.00% | – |
| Q3 2020 | $613,470,000 | +18.2% | 14,300 | +28.8% | 0.00% | – |
| Q2 2020 | $518,814,000 | – | 11,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 204,673 | $10,164,000 | 6.19% |
| CVI Holdings, LLC | 200,032 | $9,349,000 | 3.47% |
| DAFNA Capital Management LLC | 149,017 | $6,965,000 | 2.01% |
| Cormorant Asset Management, LP | 800,000 | $37,392,000 | 1.43% |
| ARK Investment Management | 1,918,835 | $89,686,000 | 0.96% |
| EAM Global Investors LLC | 30,948 | $1,447,000 | 0.65% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,362,000 | 0.61% |
| Monashee Investment Management LLC | 79,497 | $3,716,000 | 0.56% |
| EAM Investors, LLC | 40,695 | $1,902,000 | 0.42% |
| Diametric Capital, LP | 11,478 | $536,000 | 0.41% |